The association of pituitary tumors and headache

Current Neurology and Neuroscience Reports

Volumn 11, Issue 2, 2011, Pages 164-170

  Levy, Miles J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Headache; Pituitary; Tumor

Indexed keywords

ABORTIVE AGENT; ANGIOPEPTIN; ANTIMIGRAINE AGENT; CORTICOSTEROID; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; INDOMETACIN; OCTREOTIDE; PLACEBO; PROLACTIN; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5; THYROTROPIN;

ACROMEGALY; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLUSTER HEADACHE; DISEASE ASSOCIATION; DRUG RECEPTOR BINDING; GROWTH HORMONE SECRETING ADENOMA; HEADACHE; HEMICRANIA CONTINUA; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; HYPOPHYSIS TUMOR; HYPOPHYSITIS; INCIDENTALOMA; NEUROIMAGING; NONFUNCTIONING PITUITARY ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL HEMICRANIA; PROLACTIN BLOOD LEVEL; PROLACTINOMA; REVIEW; SUNCT SYNDROME; TRANSFORMED MIGRAINE;

ACROMEGALY; BRAIN NEOPLASMS; HEADACHE; HUMAN GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROLACTIN;

EID: 79955815230     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0166-7     Document Type: Review

References (50)

1. Ezzat S, Asa S, Couldwell WT, et al.: The prevalence of pituitary adenomas: a systematic review. Cancer. 2004, 101:613-19
2. Abe T, Matsumoto K, Kuwazawa J, et al.: Headache associated with pituitary adenomas. Headache 1998, 38:782-786. (Pubitemid 29031076)
3. Levy MJ, Jager HR, Powell M, et al.: Pituitary volume and headache: size is not everything. Arch Neurol 2005, 61:721-25 (Pubitemid 38637690)
4. Levy MJ, Matharu MS, Meeran K, et al.: The clinical characteristics of headache in patients with pituitary tumours. Brain 2005, 128:1921-1930. (Pubitemid 41373664)
5. Levy MJ, Bejon P, Barakat M, et al.: Acromegaly: a unique human headache model. Headache 2003, 43:794-7. (Pubitemid 36993019)
6. Levy MJ, Matharu MS, Goadsby PJ: Prolactinomas, dopamine agonists and headache: two case reports. Eur.J.Neurol 2003, 10:169-173. (Pubitemid 36308212)
7. Milos P, Havelius U, Hindfelt B: Clusterlike headache in a patient with a pituitary adenoma. With a review of the literature. Headache 1996, 36:184-188.
8. Massiou H, Launay JM, Levy C, et al.: SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology 2002, 58:1698-1699. (Pubitemid 34602912)
9. Matharu MS, Levy MJ, Merry RT, et al.: SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry. 2003, 74:1590-2.
10. Williams G, Ball JA, Lawson RA, et al.: Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J (Clin Res Ed) 1987, 295:247-8. (Pubitemid 17102182)
11. Tfelt-Hansen P, Paulson OB, Krabbe AA: Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship? Cephalalgia 1982, 2:25-28.
12. Greve E, Mai J: Cluster headache-like headaches: a symptomatic feature? A report of three patients with intracranial pathologic findings. Cephalalgia 1988, 8:79-82.
13. Porta-Etessam J, Ramos-Carrasco A, Berbel-Garcia A, et al.: Clusterlike headache as first manifestation of a prolactinoma. Headache 2001, 41:723-725. (Pubitemid 32777757)
14. Friedman AH, Wilkins RH, Kenan PD, et al.: Pituitary adenoma presenting as facial pain: report of two cases and review of the literature. Neurosurgery 1982, 10:742-745. (Pubitemid 12081477)
15. Gelabert Gonzalez M, Bollar Zabala A, Garcia Allut A: Trigeminal neuralgia as the first manifestation of craniopharyngioma. An Med Interna 1990, 7:545.
16. Gazioglu N, Tanriover N, Tuzgen S: Pituitary tumour presenting with trigeminal neuralgia as an isolated symptom. Br J Neurosurg 2000, 14:579. (Pubitemid 32055673)
17. Millan-Guerrero RO, Isais-Cardenas MA: Headache associated with pituitary adenomas. Headache 1999, 39: 522-523.
18. Gabrielli M, Gasbarrini A, Fiore G, et al.: Resolution of migraine with aura after successful treatment of a pituitary microadenoma. Cephalalgia 2002, 22: 149-150. (Pubitemid 34494138)
19. Lee AH: Pituitary adenoma causing classical migraine. Br J Neurosurg 1990, 4: 347-348.
20. Cittadini E, Matharu MS: Symptomatic trigeminal autonomic cephalalgias. Neurologist. 2009, 15:305-12. This is a review of TACs in a tertiary headache center showing a relatively high prevalence of pituitary tumors in patients with atypical and refractory presentations.
21. Sarov M, Valade D, Jublanc C, et al.: Chronic paroxysmal hemicrania in a patient with a macroprolactinoma. Cephalalgia 2006, 26: 738-41.
22. Ferrari MD, Haan J, van Seters AP: Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor. Neurology 1988, 38: 1482-1484.
23. King JT, Jr., Justice AC, Aron DC: Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab. 1997 82, 11:3625-32. (Pubitemid 27509347)
24. Karavitaki N, Thanabalasingham G, Shore HC, et al.: Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clinical Endocrinology 2006, 65:524-9 (Pubitemid 44414278)
25. S Melmed, A Colao, A Barkan, et al.: Guidelines for acromegaly management: an update. J Clin Endo Metab 2009, 94:1509-17
26. Arafah BM, Prunty D, Ybarra J, et al.: The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000, 85:1789-93. (Pubitemid 32269277)
27. David NJ: Pituitary apoplexy goes to the bar: litigation for delayed diagnosis, deficient vision, and death. J Neuroophthalmol 2006, 26:128-33.
28. Elster AD, Chen MY, Williams DW 3rd, Key LL: Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology1990, 174: 681-5.
29. Bahurel-Barrera H, Assie G, Silvera S, et al.: Inter- and intra-observer variability in detection and progression assessment with MRI of microadenoma in Cushing's disease patients followed up after bilateral adrenalectomy. Pituitary 2008, 11:263-9.
30. Levy MJ, Matharu M, Goadsby PJ: Chronic headache and pituitary tumors. Curr Pain Headache Rep 2008, 12:74-8. This is a review article outlining the management of patients with pituitary tumor-associated headache when there is no specific indication for hypophysectomy.
31. Nammour GM, Ybarra J, Naheedy MH, et al.: Incidental pituitary macroadenoma: a population-based study. Am J Med Sci. 1997, 314:287-91. (Pubitemid 27481524)
32. Yue NC, Longstreth WT, Jr., Elster AD, et al.: Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology 1997, 202:41-6. (Pubitemid 27024106)
33. Sprenger T, Goadsby PJ: What has functional neuroimaging done for primary headache ... and for the clinical neurologist? J Clin Neurosci. 2010, 17: 547-53. This is a review of the functional imaging abnormalities observed in primary headache. This is important because it may relate to some of the headache syndromes observed in pituitary tumor-associated headache
34. Ezzat S, Snyder PJ, Young WF, et al.: Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992, 117:711-718.
35. Newman CB, Melmed S, Snyder PJ, et al.: Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients-a clinical research center study. J Clin Endocrinol Metab. 1995, 80:2768-2775.
36. Newman CB, Melmed S, George A, et al.: Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab. 1998, 83:3034-3040. (Pubitemid 28500931)
37. Lancranjan I, Atkinson AB: Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group. Pituitary 1999, 1:105-114.
38. Cannavo S, Squadrito S, Curto L, et al.: Results of a two-year treatment with slow release lanreotide in acromegaly. Horm Metab Res 2000, 32:224-229. (Pubitemid 30439033)
39. Cannavo S, Squadrito S, Curto L, et al.: Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma. Horm Metab Res 2001, 33:618-624. (Pubitemid 33015966)
40. Patel YC, Srikant CB: Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors. Endocrinology 1994, 135:2814-2817. (Pubitemid 24377451)
41. Schaer JC, Waser B, Mengod G, et al.: Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. Int J Cancer 1997, 70:530-537. (Pubitemid 27149636)
42. Shimon I, Melmed S: Structure and function of somatostatin receptors in growth hormone control. J Endocrinol 1997, 155 Suppl 1:S3-6 discussion S7-8.
43. Shimon I, Yan X, Taylor JE, et al.: Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest 1997, 100:2386-2392. (Pubitemid 27500164)
44. Turpin G, Foubert L, Noel-Wekstein S, et al.: Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma. Presse Med 1991, 20:2219-2220.
45. Yoenem A, Cakyr B, Azal O, et al.: Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Endocr Regul 1999, 33:169-174. (Pubitemid 30080003)
46. May A, Lederbogen S, Diener HC: Octreotide dependency and headache: a case report. Cephalalgia 1994, 14:303-304. (Pubitemid 24257059)
47. Schindler M, Sellers LA, Humphrey PP, et al.: Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord. Neuroscience 1997, 76:225-240. (Pubitemid 26407951)
48. Matharu MS, Levy MJ, Meeran K, Goadsby PJ: Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004 56(4):488-94. (Pubitemid 39319338)
49. Kapicioglu S, Gokce E, Kapicioglu Z, et al.: Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia 1997, 17:27-30. (Pubitemid 27101417)
50. Levy MJ, Classey J, Maneesi S, et al.: The association between CGRP, Substance P and headache in pituitary adenomas. Pituitary 2004, 7: 67-71.